InvestorsHub on MSN
HeartBeam receives FDA breakthrough device designation for heart attack assessment
The designation gives HeartBeam prioritized FDA interaction as it prepares a pivotal study of its 3D ECG technology for ...
The FDA's Breakthrough Device Program is intended to speed the development and review of technologies that may provide more effective diagnosis or treatment of life-threatening conditions. The ...
"Our virtual heart test significantly outperformed several existing clinical metrics in predicting future arrhythmic events," said Natalia Trayanova, the university's inaugural Murray B. Sachs ...
BALTIMORE, May 11 (UPI) --A 3D heart assessment, based on imaging of individual patients, was shown to be more accurate at predicting heart arrhythmia and sudden cardiac arrest than other standard ...
Powered by retrospective real-world data from Dandelion Health, the American Heart Association's AI Impact Report provides a third-party evaluation of Ultromics' EchoGo® Heart Failure The independent ...
Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest pain needs to be ...
Researchers at Rochester Institute of Technology are developing technology that will be able to determine the lifespan of a heart valve with more precision. “It’s almost like a check engine light on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results